The Food and Drug Administration (FDA) has cleared a new blood test designed to help diagnose Alzheimer’s disease, which is expected to be available later this year. The blood test, known as ...
Outside advisers to the Food and Drug Administration on Monday voted unanimously that the benefits of Eli Lilly's experimental Alzheimer's treatment donanemab outweighed its risks, and agreed that ...
PrecivityAD2 is cleared for adults ≥40 with cognitive impairment symptoms and is intended to complement, not replace, standard diagnostic evaluation incorporating history, exam, cognitive testing, ...